Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Delving into the 5-Year COAPT Trial Data on Abbott's MitraClip Mitral Regurgitation device, released at ACC 2023

Ticker(s): ABT

Who's the expert?

Institution: North Shore Heart and Vascular

Board certified in Interventional Cardiology while also specializing in nuclear cardiology
manages treatment for 50 patients with Hypertrophic Cardiomyopathy
very familiar with Mavacamten, VALOR-HCM, and EXPLORER-LTE clinical trial

Interview Goal

This call will focus on the recently released 5-year long term study data of Mitraclip, a device by Abbott labs for treating mitral regurgitation. The data was released at ACC 2023.

Do you want answers to these questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.